NORRIS

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Norris Medicines Ltd.

BSE: 524414

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Trading & Distributors

15.01+0.0 (+0.07%)

23 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

15.01

P/E (TTM)

P/B

P/S (TTM)

1.98

EV/EBITDA

75.61

CAPE (5Y)

ROE (TTM)

ROCE (TTM)

2.66

ROA (TTM)

-2.10

Avg 3Y ROE

Earnings 3Y CAGR

41.40

Sales 3Y CAGR

-4.10

Sales 5Y CAGR

-7.87

Debt/Equity

Consensus TP

Strong Buy %

Promoter Holding

34.01

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Norris Medicines Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -2.44% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Norris Medicines Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

Not enough data

EBITDA FY

Norris Medicines Ltd. Shareholding Pattern

Quarterly breakdown of Norris Medicines Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	10.44	10.44	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.01	34.01	34.01	34.01	34.01	34.01	34.00	34.00	34.00	34.00	34.00	34.01	34.01
Indian Promoter	10.44	10.44	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.04	34.01	34.01	34.01	34.01	34.01	34.01	34.00	34.00	34.00	34.00	34.00	34.01	34.01
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07
Mutual Funds / UTI	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
FI/Bank/Insurance	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	89.49	89.49	65.89	65.89	65.89	65.89	65.89	65.89	65.89	65.89	65.89	65.89	65.89	65.92	65.92	65.92	65.92	65.92	65.92	65.93	65.93	65.93	65.93	65.93	65.92	65.92
Bodies Corporate	43.99	43.99	43.99	43.99	43.99	43.99	44.00	44.03	44.00	44.00	43.98	43.98	43.98	43.98	43.96	43.96	43.94	43.94	43.94	43.94	43.94	43.92	43.92	43.91	43.91	43.91
Others (incl. Retail) No. of shareholders	45.50 25,111	45.50 25,092	21.90 25,046	21.90 24,986	21.90 24,930	21.90 24,952	21.89 24,938	21.86 25,060	21.89 25,211	21.89 25,215	21.91 25,252	21.91 25,310	21.91 25,252	21.94 25,182	21.96 25,167	21.96 25,244	21.98 25,445	21.98 25,328	21.98 25,425	21.99 25,587	21.99 25,743	22.01 25,880	22.01 25,825	22.02 25,722	22.01 25,708	22.01 25,708

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Norris Medicines Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Norris Medicines Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Others
Ex-date: 22nd Aug 2013Announced on: 20th Aug 2013
The existing paid up capital has been reduced by 70 percent as a result every 10 equity shares has been consolidated into 3 equity shares.

Company Profile

Overview of Norris Medicines Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatologica...

Key personnel

Mr. Iqubal Ismail Patel

Chief Financial Officer

Ms. Priyanka Lohiya

Company Secretary

Mr. Vimal Dhirendra ShahD

Executive Director, Managing Director

Mr. Praveen J. BafnaD

Non-Executive Director

Mr. Angamuthu VadivelD

Non-Executive Independent Director

Ms. Sathya VenkatachalamD

Non-Executive Independent Director

Incorporated on

07 Sep 1990

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

15 Dec 1993

Free Float

9,24,06,170

Website

https://www.norrispharma.com/

Phone no.

+912646223462

Address

Plot No. 801/P, 901/3-5 GIDC Industrial Estate, ANKLESHWAR, 393002, India

Frequently Asked Questions

What is the current share price of Norris Medicines Ltd.?

The current share price of Norris Medicines Ltd. is ₹ 15.01 as of 23 Oct 2026.

What is the market capitalisation of Norris Medicines Ltd.?

The market capitalisation of Norris Medicines Ltd. stands at ₹ 15.01 Cr.

What is the PE ratio of Norris Medicines Ltd.?

The Price-to-Earnings (PE) ratio of Norris Medicines Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Norris Medicines Ltd.?

Norris Medicines Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of 2.66% as per the latest financial reports.

What is the 52-week high and low of Norris Medicines Ltd.?

The 52-week high of Norris Medicines Ltd. is - and the 52-week low is -.

What is the dividend yield of Norris Medicines Ltd.?

The dividend yield of Norris Medicines Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Norris Medicines Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.07% and retail/public investors hold 22.01% of Norris Medicines Ltd. shares.

What sector does Norris Medicines Ltd. belong to?

Norris Medicines Ltd. operates in the Services sector.

What is the beta of Norris Medicines Ltd.?

The beta of Norris Medicines Ltd. is 0.28, indicating its price volatility relative to the broader market. Over the past 1 year, Norris Medicines Ltd. has delivered an absolute return of -5.78%.

What is the RSI of Norris Medicines Ltd.?

The 14-day Relative Strength Index (RSI) of Norris Medicines Ltd. is 41.10, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Norris Medicines Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Norris Medicines Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions